Understanding blood clotting issues after COVID-19 infection and exploring new treatments
Molecular pathogenesis of COVID-19-associated coagulopathy and new therapeutic approaches
This study is looking into how COVID-19 can cause blood clotting issues and problems with blood vessels, and it aims to find better treatments to help people who are dealing with these long-term effects.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11004157 on NIH RePORTER |
What this research studies
This research investigates the blood clotting problems that many patients experience after being infected with COVID-19. It focuses on understanding how the virus affects blood vessels and leads to conditions like blood clots and organ dysfunction. The researchers will explore various potential treatments to reduce these complications and improve patient outcomes. By studying the underlying mechanisms of these issues, the research aims to provide insights that could help manage and treat patients suffering from long-term effects of COVID-19.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced severe COVID-19 infections and are facing complications related to blood clotting.
Not a fit: Patients who have not been infected with COVID-19 or those without any blood coagulation issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly reduce blood clotting complications in COVID-19 patients.
How similar studies have performed: Other research has shown promising results in understanding blood clotting issues related to COVID-19, indicating that this area of study is both relevant and necessary.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Aiolfi, Roberto — Scripps Research Institute, the
- Study coordinator: Aiolfi, Roberto
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.